活检确诊急性间质性肾炎的临床病理特征与肾脏结局
该回顾性研究纳入2012至2023年Mayo Clinic经肾活检确诊的166例急性间质性肾炎患者,分析病因、临床特征、治疗与肾脏结局。药物为主要病因(67%),6个月内76%患者肾功能恢复;中重度间质纤维化与肾小管萎缩(IFTA)及需要透析与未恢复相关,而活检前已诊断AIN与恢复正相关。激素治疗未显著影响恢复。
要点
- 药物是活检确诊AIN的主要病因(67%),自身免疫病占20%,感染占6%。
- 6个月内76%患者肾功能恢复,药物相关AIN恢复率高于其他病因(81% vs 66%,P=0.04)。
- 中重度IFTA和需要透析是不恢复的显著预测因素,激素治疗未显著影响恢复。
核心结论
- 中重度IFTA和需要透析与活检确诊AIN患者肾脏结局较差显著相关。
- 药物相关AIN的肾脏恢复率高于其他病因。
- 激素治疗在整体队列或药物诱导AIN中未显著影响肾脏恢复。
研究设计与样本
- 回顾性研究,纳入2012至2023年Mayo Clinic经肾活检确诊的166例AIN患者。
- 收集人口学、临床、实验室和病理数据,主要结局为6个月内肾功能恢复。
- 统计分析包括单变量和多变量逻辑回归、Kaplan-Meier生存分析和Cox比例风险模型。
主要发现
- 药物是AIN主要病因(67%),自身免疫病占20%,感染占6%。
- 6个月内76%患者达到肾脏恢复。
- 多变量分析显示中重度IFTA和需要透析与未恢复相关,活检前诊断AIN与恢复正相关。
- 药物相关AIN恢复率81%,其他病因66%(P=0.04)。
- 81%患者接受激素治疗,但激素治疗未显著影响肾脏恢复。
关键数值与推荐
- 药物相关AIN恢复率81% vs 其他病因66%(P=0.04)。
- 中重度IFTA和需要透析为恢复降低的显著预测因素。
临床怎么用
- 对活检确诊AIN患者,应评估IFTA程度和是否需透析以辅助预后判断。
- 药物相关AIN患者肾脏恢复可能性较高,但仍需关注IFTA和透析需求。
- 激素治疗对肾脏恢复的获益在本队列中未显显著,临床决策需个体化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Acute interstitial nephritis (AIN) is a significant cause of acute kidney injury, with varying etiologies and outcomes. This study aimed to examine the causes, clinical characteristics, management, and kidney outcomes in patients with biopsy-confirmed AIN. METHODS: A retrospective review was conducted on 166 patients diagnosed with AIN through kidney biopsy at Mayo Clinic between 2012 and 2023. Demographic, clinical, laboratory, and pathological data were collected. The primary outcome was kidney function recovery within the first 6 months. Statistical analyses included univariable and multivariable logistic regression, Kaplan-Meier survival analysis, and Cox proportional hazards modeling. RESULTS: Medications were the primary cause of AIN (67%), followed by autoimmune diseases (20%) and infections (6%). Within 6 months, 76% of patients achieved kidney recovery. Multivariable analysis indicated that moderate to severe interstitial fibrosis and tubular atrophy (IFTA) and dialysis requirement were associated with nonrecovery, whereas a prebiopsy diagnosis of AIN was positively associated with kidney recovery. Drug-related AIN had higher recovery rates compared to all other causes (81% vs. 66%, P = 0.04), and moderate to severe IFTA and dialysis need remained significant predictors of decreased recovery. Steroid therapy, used in 81% of patients, did not significantly influence kidney recovery in the overall cohort or in drug-induced AIN. CONCLUSION: This study provides insights into the characteristics and outcomes of biopsy-confirmed AIN. IFTA and dialysis requirement were significant factors associated with worse kidney outcomes. These findings may help inform clinical management and prognostication in patients with AIN.
引用
- Miao J, Thongprayoon C, Krisanapan P, et al. Clinicopathological Characteristics and Kidney Outcomes in Biopsy-Confirmed Acute Interstitial Nephritis. Kidney Int Rep. 2024. PMID: 39698351. doi:10.1016/j.ekir.2024.09.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。